Literature DB >> 33641056

Quantitative and qualitative evaluation of sequential PET/MRI using a newly developed mobile PET system for brain imaging.

Mizue Suzuki1, Yasutaka Fushimi2, Tomohisa Okada3, Takuya Hinoda1, Ryusuke Nakamoto1, Yoshiki Arakawa4, Nobukatsu Sawamoto5, Kaori Togashi1, Yuji Nakamoto1.   

Abstract

PURPOSE: To evaluate the clinical feasibility of a newly developed mobile PET system with MR-compatibility (flexible PET; fxPET), compared with conventional PET (cPET)/CT for brain imaging.
METHODS: Twenty-one patients underwent cPET/CT with subsequent fxPET/MRI using 18F-FDG. As qualitative evaluation, we visually rated image quality of MR and PET images using a four-point scoring system. We evaluated overall image quality for MR, while we evaluated overall image quality, sharpness and lesion contrast. As quantitative evaluation, we compared registration accuracy between two modalities [(fxPET and MRI) and (cPET and CT)] measuring spatial coordinates. We also examined the accuracy of regional 18F-FDG uptake.
RESULTS: All acquired images were of diagnostic quality and the number of detected lesions did not differ significantly between fxPET/MR and cPET/CT. Mean misregistration was significantly larger with fxPET/MRI than with cPET/CT. SUVmax and SUVmean for fxPET and cPET showed high correlations in the lesions (R = 0.84, 0.79; P < 0.001, P = 0.002, respectively). In normal structures, we also showed high correlations of SUVmax (R = 0.85, 0.87; P < 0.001, P < 0.001, respectively) and SUVmean (R = 0.83, 0.87; P < 0.001, P < 0.001, respectively) in bilateral caudate nuclei and a moderate correlation of SUVmax (R = 0.65) and SUVmean (R = 0.63) in vermis.
CONCLUSIONS: The fxPET/MRI system showed image quality within the diagnostic range, registration accuracy below 3 mm and regional 18F-FDG uptake highly correlated with that of cPET/CT.

Entities:  

Keywords:  Mobile PET; PET/CT; PET/MRI

Mesh:

Year:  2021        PMID: 33641056     DOI: 10.1007/s11604-021-01105-9

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  38 in total

1.  First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.

Authors:  Alexander Drzezga; Michael Souvatzoglou; Matthias Eiber; Ambros J Beer; Sebastian Fürst; Axel Martinez-Möller; Stephan G Nekolla; Sibylle Ziegler; Carl Ganter; Ernst J Rummeny; Markus Schwaiger
Journal:  J Nucl Med       Date:  2012-04-25       Impact factor: 10.057

Review 2.  PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

Authors:  Denys J Loeffelbein; Michael Souvatzoglou; Veronika Wankerl; Axel Martinez-Möller; Julia Dinges; Markus Schwaiger; Ambros J Beer
Journal:  J Oral Maxillofac Surg       Date:  2011-05-20       Impact factor: 1.895

Review 3.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

4.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Authors:  Gerald Antoch; Nina Saoudi; Hilmar Kuehl; Gerlinde Dahmen; Stefan P Mueller; Thomas Beyer; Andreas Bockisch; Jörg F Debatin; Lutz S Freudenberg
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

5.  Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.

Authors:  Christopher Scarfone; William C Lavely; Anthony J Cmelak; Dominique Delbeke; William H Martin; Dean Billheimer; Dennis E Hallahan
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

Review 6.  Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.

Authors:  Hiroshi Matsuda; Yoko Shigemoto; Noriko Sato
Journal:  Jpn J Radiol       Date:  2019-09-06       Impact factor: 2.374

7.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

8.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

Authors:  Rachel Bar-Shalom; Nikolai Yefremov; Ludmila Guralnik; Diana Gaitini; Alex Frenkel; Abraham Kuten; Hernan Altman; Zohar Keidar; Ora Israel
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

9.  Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.

Authors:  Christiaan Schiepers; Magnus Dahlbom
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

10.  Prediction of Hypoxia in Brain Tumors Using a Multivariate Model Built from MR Imaging and 18F-Fluorodeoxyglucose Accumulation Data.

Authors:  Yukie Shimizu; Kohsuke Kudo; Hiroyuki Kameda; Taisuke Harada; Noriyuki Fujima; Takuya Toyonaga; Khin Khin Tha; Hiroki Shirato
Journal:  Magn Reson Med Sci       Date:  2019-10-15       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.